These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1687073

  • 21. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP, Dubinskiĭ AA, Tereshkin IG.
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [Abstract] [Full Text] [Related]

  • 22. [Morphologic and functional abnormalities of the cardiovascular system in patients with hepatic cirrhosis].
    Piscione F, Manganiello V, Viola O, Chiariello M.
    Ital Heart J Suppl; 2003 Feb; 4(2):85-95. PubMed ID: 12762257
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Vasodilator agents in portal hypertension].
    Combis JM, Vinel JP.
    Gastroenterol Clin Biol; 1991 Feb; 15(12):881-7. PubMed ID: 1686004
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM, Graziadei I, Wiedermann CJ, Kneussl MP, Vogel W.
    Wien Klin Wochenschr; 2000 Jul 28; 112(14):637-40. PubMed ID: 11008327
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
    Sugimachi K, Soejima Y, Morita K, Ueda S, Fukuhara T, Nagata S, Ikegami T, Taketomi A, Maehara Y.
    Transplant Proc; 2009 Jun 28; 41(5):1976-8. PubMed ID: 19545772
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Doppler evaluation of the effects of pharmacological treatment of portal hypertension.
    Piscaglia F, Gaiani S, Donati G, Masi L, Bolondi L.
    Ultrasound Med Biol; 1999 Jul 28; 25(6):923-32. PubMed ID: 10461720
    [Abstract] [Full Text] [Related]

  • 38. Vascular deterioration in cirrhosis: the big picture.
    Bosch J.
    J Clin Gastroenterol; 2007 Jul 28; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [Abstract] [Full Text] [Related]

  • 39. Pharmacologic management of portal hypertension.
    Berzigotti A, Bosch J.
    Clin Liver Dis; 2014 May 28; 18(2):303-17. PubMed ID: 24679496
    [Abstract] [Full Text] [Related]

  • 40. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.
    Garbuzenko DV.
    World J Gastroenterol; 2015 May 28; 21(20):6117-26. PubMed ID: 26034348
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.